- Home
- CVM vs SSKN Comparison
CVM vs SSKN Comparison
Compare CVM & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVM
- SSKN
- Stock Information
- Founded
- CVM 1983
- SSKN 1989
- Country
- CVM United States
- SSKN United States
- Employees
- CVM N/A
- SSKN N/A
- Industry
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- SSKN Medical/Dental Instruments
- Sector
- CVM Health Care
- SSKN Health Care
- Exchange
- CVM Nasdaq
- SSKN Nasdaq
- Market Cap
- CVM 11.8M
- SSKN 9.7M
- IPO Year
- CVM 1987
- SSKN 2005
- Fundamental
- Price
- CVM $3.46
- SSKN $2.45
- Analyst Decision
- CVM
- SSKN Strong Buy
- Analyst Count
- CVM 0
- SSKN 1
- Target Price
- CVM N/A
- SSKN $6.00
- AVG Volume (30 Days)
- CVM 1.6M
- SSKN 18.4K
- Earning Date
- CVM 08-14-2025
- SSKN 08-13-2025
- Dividend Yield
- CVM N/A
- SSKN N/A
- EPS Growth
- CVM N/A
- SSKN N/A
- EPS
- CVM N/A
- SSKN N/A
- Revenue
- CVM N/A
- SSKN $33,620,000.00
- Revenue This Year
- CVM N/A
- SSKN $3.31
- Revenue Next Year
- CVM N/A
- SSKN $9.67
- P/E Ratio
- CVM N/A
- SSKN N/A
- Revenue Growth
- CVM N/A
- SSKN 3.30
- 52 Week Low
- CVM $1.98
- SSKN $2.10
- 52 Week High
- CVM $66.60
- SSKN $3.80
- Technical
- Relative Strength Index (RSI)
- CVM 57.66
- SSKN 50.75
- Support Level
- CVM $2.24
- SSKN $2.30
- Resistance Level
- CVM $2.71
- SSKN $2.66
- Average True Range (ATR)
- CVM 0.51
- SSKN 0.21
- MACD
- CVM 0.25
- SSKN 0.02
- Stochastic Oscillator
- CVM 25.61
- SSKN 28.99
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.